Karyopharm Therapeutics (KPTI) Revenue (2012 - 2026)
Karyopharm Therapeutics (KPTI) posted Revenue of $33.43 million for Q2 2026, down 11.9% from $37.93 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Revenue (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Karyopharm Therapeutics was $149.48 million, up 8.9% year-over-year; for FY2025, it came in at $146.07 million, up 0.6% from FY2024.
- Annual Revenue shows a five-year compound annual growth rate of 6.2% (FY2020 to FY2025).
- In prior years, Karyopharm Therapeutics' Revenue was $145.24 million in FY2024 (-0.5%), $146.03 million in FY2023 (-7.0%), $157.07 million in FY2022 (-25.1%) and $209.82 million in FY2021 (+94.1%).
- The Q2 2026 figure stands as the lowest quarterly Revenue since Q1 2025.
- On a year-over-year basis, Revenue increased in three of the last seven quarters, with an average decline of 1.3%.
- The strongest year-over-year quarter for Revenue in the past five years was Q4 2021, with growth of 259.7%; the weakest was Q4 2022, with a decline of 73.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Karyopharm Therapeutics | 35.30 Mn | -191.12 Mn | 32.35 Mn | 33.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.43 Mn |
| Dec 31, 2025 | 34.08 Mn |
| Sep 30, 2025 | 44.04 Mn |
| Jun 30, 2025 | 37.93 Mn |
| Mar 31, 2025 | 30.02 Mn |
| Dec 31, 2024 | 30.54 Mn |
| Sep 30, 2024 | 38.78 Mn |
| Jun 30, 2024 | 42.79 Mn |
| Mar 31, 2024 | 33.13 Mn |
| Dec 31, 2023 | 33.75 Mn |
| Sep 30, 2023 | 36.01 Mn |
| Jun 30, 2023 | 37.58 Mn |
| Mar 31, 2023 | 38.70 Mn |
| Dec 31, 2022 | 33.58 Mn |
| Sep 30, 2022 | 36.15 Mn |
| Jun 30, 2022 | 39.68 Mn |
| Mar 31, 2022 | 47.67 Mn |
| Dec 31, 2021 | 126.27 Mn |
| Sep 30, 2021 | 37.69 Mn |
| Jun 30, 2021 | 22.60 Mn |
API Access
Karyopharm Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();